Cetuximab

An endogenous ceramide, generated by ceramide synthase 6, that acts a lipid second messenger to regulate apoptosis and stress signaling.

Cell Line Origin Human Caucasian Cervical carcinoma Cell Line Description Established from a cervical carcinoma of a 41 year old Caucasian female. Cells form stratified, epithelial colonies and retain properties of squamous cell differentiation in

C-8 ceramide is a cell-permeable analog of naturally occurring ceramides. Unlike C-2 ceramide, it is metabolized within cells to generate natural ceramides, often causing a dramatic increase in cellular ceramide levels.

C-8 ceramide is a cell-permeable analog of naturally occurring ceramides. Unlike C-2 ceramide, it is metabolized within cells to generate natural ceramides, often causing a dramatic increase in cellular ceramide levels.

C-8 ceramide is a cell-permeable analog of naturally occurring ceramides. Unlike C-2 ceramide, it is metabolized within cells to generate natural ceramides, often causing a dramatic increase in cellular ceramide levels.

C-8 ceramide is a cell-permeable analog of naturally occurring ceramides. Unlike C-2 ceramide, it is metabolized within cells to generate natural ceramides, often causing a dramatic increase in cellular ceramide levels.

C-8 ceramine is an analog of C-8 ceramide in which the carbonyl group of the ceramide is replaced by a methylene group. At a concentration of 10 &microM, C-8 ceramine induces maximal DNA fragmentation in U937 cells after 6 hours of incubation,

C6-NBD Ceramide

C6-NBD Ceramide

InformationC75 trans C75 trans (trans-C75, (±)-C75) is a novel, potent synthetic inhibitor of fatty acid synthase (FAS/FASN) with IC50 of 35 μM and 50 μM in clonogenic assays and spheroid growth assay, respectively. C75 is used as a tool for

CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.

Cadonilimab (anti-PD-1&amp:CTLA4) is a targeting PD1/CTLA4 IgG1 scaffold Fc-engineered humanized antibody. Cadonilimab (anti-PD-1&amp:CTLA4) can be used for researching metastatic cervical cancer.